Risk of internal malignancies, cutaneous malignant melanoma and non‐melanoma skin cancer among patients with vitiligo: a systematic review and meta‐analysis

Journal of the European Academy of Dermatology and VenereologyVolume 36, Issue 10 p. e829-e831 Letter to the Editor Risk of internal malignancies, cutaneous malignant melanoma and non-melanoma skin cancer among patients with vitiligo: a systematic review and meta-analysis V.S. Long, Corresponding Author V.S. Long [email protected] orcid.org/0000-0002-5445-5698 Division of Dermatology, Department of Medicine, National University Healthcare System, Singapore, SingaporeCorrespondence: V.S. Long. E-mail: [email protected]Search for more papers by this authorY.X.T. Law, Y.X.T. Law Department of Urology, National University Hospital, National University Healthcare System, Singapore, SingaporeSearch for more papers by this authorY.W. Yew, Y.W. Yew Medical Department, National Skin Cancer, Singapore, SingaporeSearch for more papers by this authorC.-E.E. Choi, C.-E.E. Choi orcid.org/0000-0002-2059-3478 Division of Dermatology, Department of Medicine, National University Healthcare System, Singapore, SingaporeSearch for more papers by this author V.S. Long, Corresponding Author V.S. Long [email protected] orcid.org/0000-0002-5445-5698 Division of Dermatology, Department of Medicine, National University Healthcare System, Singapore, SingaporeCorrespondence: V.S. Long. E-mail: [email protected]Search for more papers by this authorY.X.T. Law, Y.X.T. Law Department of Urology, National University Hospital, National University Healthcare System, Singapore, SingaporeSearch for more papers by this authorY.W. Yew, Y.W. Yew Medical Department, National Skin Cancer, Singapore, SingaporeSearch for more papers by this authorC.-E.E. Choi, C.-E.E. Choi orcid.org/0000-0002-2059-3478 Division of Dermatology, Department of Medicine, National University Healthcare System, Singapore, SingaporeSearch for more papers by this author First published: 10 June 2022 https://doi.org/10.1111/jdv.18310Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700. 10.1136/bmj.b2700 PubMedWeb of Science®Google Scholar 2Symons MJ, Moore DT. Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 2002; 55: 893–899. 10.1016/S0895-4356(02)00443-2 CASPubMedWeb of Science®Google Scholar 3Helvind NM, Hölmich LR, Smith S et al. Incidence of in situ and invasive melanoma in Denmark from 1985 through 2012: a National Database Study of 2 4059 melanoma cases. JAMA Dermatol 2015; 151: 1087–1095. 10.1001/jamadermatol.2015.1481 PubMedWeb of Science®Google Scholar 4Valejo Coelho MM, Matos TR, Apetato M. The dark side of the light: mechanisms of photocarcinogenesis. Clin Dermatol 2016; 34: 563–570. 10.1016/j.clindermatol.2016.05.022 PubMedWeb of Science®Google Scholar 5Ju HJ, Han JH, Kim MS et al. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25 694 patients with vitiligo. J Am Acad Dermatol 2021; 84: 1619–1627. 10.1016/j.jaad.2021.01.067 CASPubMedWeb of Science®Google Scholar Citing Literature Volume36, Issue10October 2022Pages e829-e831 ReferencesRelatedInformation